Inhibition of L‐{18F}fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography
- 1 August 1986
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 20 (2) , 258-262
- https://doi.org/10.1002/ana.410200212
Abstract
The brain uptake of L-{18F}fluorodopa was measured by positron emission tomography in a healthy male volunteer both under fasting conditions and during intravenous amino acid loading. A significant reduction of tracer uptake into the brain was demonstrated with amino acid loading. This finding represents the first direct evidence for competition between L-dopa and other amino acids for uptake across the blood–brain barrier obtained in vivo in a human subject. It underlines the possible importance of interference by dietary amino acids with the therapeutic actions of L-dopa in Parkinson's disease.This publication has 19 references indexed in Scilit:
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- Striatal dopamine metabolism in living monkeys examined by positron emission tomographyBrain Research, 1983
- Dopamine visualized in the basal ganglia of living manNature, 1983
- Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseasesJournal of Inherited Metabolic Disease, 1982
- Effects of fluoro-dopamines on dopamine receptors (D1, D2, D3 sites)Biochemical Pharmacology, 1981
- Intracerebral dopamine metabolism studied by a novel radioisotope techniqueJournal of Pharmacy and Pharmacology, 1976
- DO CHANGES IN BLOOD LEVELS OF OTHER AROMATIC AMINOACIDS INFLUENCE LEVODOPA THERAPY?The Lancet, 1976
- SYNTHETIC AMINO ACIDS AND THE NATURE OF l‐DOPA TRANSPORT AT THE BLOOD‐BRAIN BARRIERJournal of Neurochemistry, 1975
- Protein Intake and Treatment of Parkinson's Disease with LevodopaNew England Journal of Medicine, 1975
- “On‐off” phenomenon with levodopa therapy in parkinsonismNeurology, 1974